Treatment of cancer with phlorizin and its derivatives
Patent 4684627 Issued on August 4, 1987. Estimated Expiration Date: 
August 13, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 13, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References3523937 InventorsApplicationNo. 06/640170 filed on 08/13/1984US Classes:514/25, O-glycoside536/18.1, Polycyclo ring system (e.g., hellebrin, etc.)536/18.2, Containing -C(=X)X- wherein the X's are the same or diverse chalcogens536/4.1O- or S- GlycosidesExaminersPrimary: Brown, Johnnie R.Assistant: Moezie, F. T. Attorney, Agent or FirmInternational ClassesA61K 31/12 (20060101)A61K 31/40 (20060101) C07H 17/07 (20060101) C07H 17/00 (20060101) AbstractPhlorizin, its gluconuride and 4-deoxyphloretin-2-D-glucoside are used in treatment of cancer, particularly in combination with radio frequency thermotherapy and other modalities to accentuate the effect of such thermotherapy or other modality.Other References
|
| ||||||||||||||
